1. Home
  2. AIFA vs FEMY Comparison

AIFA vs FEMY Comparison

Compare AIFA & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo All In FutureTech Alliance Inc. Common Stock

AIFA

All In FutureTech Alliance Inc. Common Stock

BUY

Current Price

$4.00

Market Cap

27.2M

ML Signal

BUY

FEMY

Femasys Inc.

BUY

Current Price

$1.69

Market Cap

22.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AIFA
FEMY
Founded
N/A
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.2M
22.4M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
AIFA
FEMY
Price
$4.00
$1.69
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $14.33
AVG Volume (30 Days)
★ 387.2K
92.8K
Earning Date
11-18-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 44.71
EPS
★ N/A
N/A
Revenue
★ $7,655,039.00
$2,293,313.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$328.45
P/E Ratio
★ N/A
N/A
Revenue Growth
20.50
★ 40.77
52 Week Low
$1.52
$0.29
52 Week High
$8.93
$6.29

Technical Indicators

Market Signals
Indicator
AIFA
FEMY
Relative Strength Index (RSI) 45.06 29.88
Support Level $2.80 $0.40
Resistance Level $8.93 $3.21
Average True Range (ATR) 0.78 0.19
MACD -0.28 -0.03
Stochastic Oscillator 4.96 17.95

Price Performance

Historical Comparison
AIFA
FEMY

About AIFA All In FutureTech Alliance Inc. Common Stock

All In FutureTech Alliance Inc operates an AI-focused digital infrastructure platform. Its activities include opportunities in AI infrastructure, silicon photonics-enabled computing, fiber-optic network transmission, digital infrastructure services, and technology-related initiatives. The company is also developing the AIFA platform, which is intended to combine AI computing capacity, fiber-optic network infrastructure, AI education, and AI-related applications.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: